Novozymes A/S
NVZMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $28,085 | $210,039 | $185,627 | $180,352 |
| - Cash | $329 | $328 | $250 | $280 |
| + Debt | $3,637 | $3,322 | $1,699 | $1,797 |
| Enterprise Value | $31,394 | $213,033 | $187,077 | $181,868 |
| Revenue | $1,246 | $7,598 | $8,043 | $7,465 |
| % Growth | -83.6% | -5.5% | 7.7% | – |
| Gross Profit | $637 | $4,062 | $4,436 | $4,573 |
| % Margin | 51.1% | 53.5% | 55.2% | 61.3% |
| EBITDA | $389 | $2,659 | $3,081 | $2,756 |
| % Margin | 31.2% | 35% | 38.3% | 36.9% |
| Net Income | $161 | $1,021 | $1,388 | $902 |
| % Margin | 13% | 13.4% | 17.3% | 12.1% |
| EPS Diluted | 0.35 | 0.29 | 0.4 | 0.53 |
| % Growth | 20.7% | -27.5% | -24.5% | – |
| Operating Cash Flow | $546 | $320 | $106 | $492 |
| Capital Expenditures | -$112 | -$82 | -$55 | -$212 |
| Free Cash Flow | $435 | $238 | $51 | $280 |